Boston Business Journal

New Boston-Based VC Fund Has $50M for Blood Tech Startups

A nearly-60-year-old blood center in New York is setting aside $50 million to invest in new blood-related technologies through a Boston-based venture arm

The New York Blood Center unveiled a $50 million investment fund, NYBC Ventures, on Thursday. The financing is tied to proceeds from a solvent detergent plasma process used for blood purification around the world, the patent for which NYBC owns.

Meg Wood, NYBC Ventures.